Q4 2023 · 13F-HR
Foresite Capital Management V, LLCholdings as filed
Filed 2024-02-13 · accession 0001104659-24-019707
$73.4M
Reported value
5
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 433000106 | HIMS | Hims & Hers Health, Inc. | $34.1M | 46.5% | 3,833,381 | Common | SOLE |
| 88369M101 | — | Theseus Pharmaceuticals, Inc. | $16.6M | 22.7% | 4,108,796 | Common | SOLE |
| 254604101 | IRON | Disc Medicine, Inc. | $14.1M | 19.2% | 243,513 | Common | SOLE |
| 49705R105 | KNTEUSD | Kinnate Biopharma Inc. | $8.4M | 11.4% | 3,525,957 | Common | SOLE |
| 90138Q108 | — | 23andMe Holding Co. | $212,115 | 0.29% | 232,200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.